| Financial Year |
March 31 2023 |
| Monetary Funds |
213,608,125.84 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
237,313,320.24 |
| Accounts Receivable |
1,734,882,041.61 |
| Advances to Suppliers |
82,681,661.34 |
| Other Receivables |
94,408,085.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,798,395,394.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
193,420,067.64 |
| Other Current Assets |
171,435,333.79 |
| Total Current Assets |
4,852,799,428.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
379,972,218.62 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,090,564,929.99 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
350,084,408.49 |
| R&D expenses |
284,604,136.10 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,591,113.27 |
| Deferred Income Tax Assets |
134,977,216.67 |
| Other Non-Current Assets |
5,876,893.79 |
| Sub-Total of Non-Current Assets |
2,256,057,941.39 |
| Total Assets |
7,108,857,369.76 |
| Short-Term Loans |
1,061,872,823.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
454,025,132.65 |
| Accounts Payable |
1,524,651,864.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,893,341.48 |
| Taxes Payable |
6,107,168.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
131,147,282.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
172,395,192.84 |
| Other Current Liabilities |
42,183,286.28 |
| Sub-Total of Current Liabilities |
3,746,334,979.00 |
| Long-term Loans |
552,362,575.52 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,724,774.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
671,002,393.09 |
| Total Liabilities |
4,417,337,372.09 |
| Paid-In Capital(Or Share Stock) |
211,429,127.00 |
| Capital Surplus |
1,003,488,871.04 |
| Surplus Reserve |
166,854,825.68 |
| LESS:Treasury Stock |
73,887,780.85 |
| Undistributed Profits |
1,354,065,920.65 |
| Minority Stockholder's Interest |
29,569,034.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,661,950,963.52 |
| Owner's Equity（Stockholder's Equity） |
2,691,519,997.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,108,857,369.76 |
